2001
$40M
from 10 investors over 10 rounds
VaxInnate Corporation raised $6M on October 2, 2014
Investors: Saints Capital
VaxInnate Corporation raised $2.2M on April 4, 2013
Investors: National Institute of Allergy and Infectious Diseases (NIAID)
VaxInnate Corporation raised $30M on June 14, 2009
Investors: New Leaf Venture Partners, Canaan, HealthCare Ventures LLC and Wellcome Trust
VaxInnate Corporation raised $40M on October 25, 2006
Investors: Canaan, HealthCare Ventures LLC and New Leaf Venture Partners
VaxInnate Corporation raised $23M on March 12, 2004
Investors: HealthCare Ventures LLC